(Q43153504)

14 November 2017

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation (English)

1 reference

14 November 2017

1 reference

antibiotic resistance

1 reference

4

Toshifumi Hibi

1 reference

14 November 2017

Hidekazu Suzuki

1

1 reference

14 November 2017

Toshihiro Nishizawa

series ordinal

2

1 reference

14 November 2017

Hiroe Muraoka

series ordinal

3

1 reference

14 November 2017

language of work or name

English

0 references

publication date

2 February 2009

1 reference

Antimicrobial Agents and Chemotherapy

14 November 2017

1 reference

14 November 2017

53

1 reference

14 November 2017

4

1 reference

14 November 2017

1720-1721

1 reference

Helicobacter pylori: present status and future prospects in Japan

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663081

Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19188389

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19188389

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00049-09

1 reference

release_nptdxo7q2rh3lctls3g6rquirq

14 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nptdxo7q2rh3lctls3g6rquirq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 November 2017

1 reference